Eurazeo Patrimoine, the Eurazeo division specializing in investments in tangible assets, is pleased to Announce the acquisition of C2S Group from Bridgepoint. C2S Group is the eighth largest private clinic operator in France and a regional leader in Auvergne, Rhône-Alpes and Burgundy Franche-Comté.
Capitalizing on recent investments in modernizing the group and improving its operating performance, C2S will continue to accelerate its development strategy, particularly through external growth and confirm its position as a benchmark health care provider in the Central-Easternregion. It will be supported by Eurazeo Patrimoine’s experience in accompanying companies, combined with its real estate management expertise.
Eurazeo Patrimoine and Bridgepoint signed an agreement in January 2018 for the purpose of this transaction. Eurazeo Patrimoine has currently invested c.€103 million for 87% of the share capital, alongside management. Group medical practitioners and a minority co-investor are expected to enter the share capital at a later date.
***
About C2S Group
C2S Group is the eighth largest private clinic operator in France and a regional leader in Auvergne, Rhône-Alpes and Burgundy Franche-Comté. It operates 11 clinics, primarily specializing in short and medium-length stays in general medicine, surgery and follow-up care. It also owns the buildings for seven of its clinics. The group has around 500 medical practitioners, who are partners in the group’s governance and nearly 1,800 employees. In 2017, it treated over 250,000 patients (75% as outpatients) and reported revenue of €161 million.
About Eurazeo
With a diversified portfolio of approximately €15 billion in assets under management, including €1 billion from third parties, Eurazeo is a leading global investment company with offices in Paris and Luxembourg, New York, Shanghai and Sao Paulo. Its purpose and mission is to identify, accelerate and enhance the transformation potential of the companies in which it invests. The firm covers most private equity segments through its five business divisions – Eurazeo Capital, Eurazeo Croissance, Eurazeo PME, Eurazeo Patrimoine and Eurazeo Brands. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. As a global long-term shareholder, the firm offers deep sector expertise, a gateway to global markets, and a stable foothold for transformational growth to the companies it supports.
>
Eurazeo is listed on Euronext Paris.
>
ISIN: FR0000121121
–
Bloomberg: RF FP
–
Reuters: EURA.PA
